Biotechnology companies play a vital role in advancing medical innovations and therapies, including breakthroughs and the development of novel therapies for various diseases.
The PRISM Emerging Biotech Index tracks small and micro-cap stocks that are contributing to healthcare innovation and economic growth.
| PRISM Biotech IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| -1.88% | $114.48 | 14.48% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Equillium, Inc. | EQ | $1.29 | -2.27% | 469 | 807 | $82 | $0.73 | 75.68% |
| Immuron Limited | IMRN | $0.88 | -3.52% | 16 | 251 | $6 | $1.90 | -53.68% |
| Kamada Ltd. | KMDA | $8.09 | -0.49% | 94 | 44 | $467 | $6.16 | 31.33% |
| iBio, Inc. | IBIO | $0.73 | -4.00% | 452 | 956 | $52 | $1.38 | -47.10% |
| Palisade Bio, Inc. | PALI | $1.12 | -1.75% | 1,459 | 3,461 | $201 | $0.58 | 93.47% |
| BioLineRx Ltd. | BLRX | $1.30 | -3.70% | 13 | 54 | $6 | $1.53 | -15.03% |
| Immatics N.V. | IMTX | $6.39 | -1.99% | 586 | 478 | $956 | $10.72 | -40.39% |
| Vaxart, Inc. | VXRT | $0.37 | -2.37% | 67 | 391 | $90 | $0.61 | -39.24% |
| Capricor Therapeutics, Inc. | CAPR | $9.53 | -6.93% | 3,653 | 1,534 | $552 | $5.12 | 86.13% |
| Lisata Therapeutics, Inc. | LSTA | $1.21 | -5.47% | 105 | 108 | $11 | $2.78 | -56.47% |
| NeuroSense Therapeutics Ltd. | NRSN | $1.69 | -3.98% | 18 | 158 | $3 | $0.80 | 111.25% |
| Addex Therapeutics Ltd | ADXN | $4.06 | -23.25% | 551 | 4 | $5 | $6.30 | -35.54% |
| Metagenomi, Inc. Common Stock | MGX | $0.69 | -3.12% | 119 | 181 | $26 | $10.31 | -93.31% |
| Annexon, Inc. | ANNX | $3.92 | -1.26% | 2,585 | 3,508 | $642 | $4.84 | -19.01% |
| Rezolute, Inc. | RZLT | $3.66 | -5.56% | 5,729 | 1,887 | $354 | $1.02 | 260.59% |
| Foghorn Therapeutics Inc. | FHTX | $2.07 | 0.98% | 534 | 245 | $124 | $8.45 | -75.50% |
| Innate Pharma S.A. | IPHA | $1.38 | -7.38% | 8 | 68 | $154 | $5.72 | -75.87% |
| Chemomab Therapeutics Ltd. | CMMB | $1.53 | 9.29% | 85 | 129 | $10 | $0.54 | 184.49% |
| Cerenome, Inc. | CNSY | $0.95 | 23.32% | 8,014 | 0 | $7 | $1.85 | -48.65% |
| Ardelyx, Inc. | ARDX | $3.09 | -0.96% | 2,380 | 4,027 | $777 | $6.05 | -48.93% |
| Eupraxia Pharmaceuticals Inc. | EPRX | $8.15 | 4.35% | 774 | 307 | $548 | $4.16 | 95.86% |
| Taysha Gene Therapies, Inc. | TSHA | $4.10 | -2.61% | 2,475 | 3,039 | $1,332 | $1.71 | 139.77% |
| Entrada Therapeutics, Inc. | TRDA | $5.09 | -1.55% | 792 | 466 | $199 | $15.17 | -66.45% |
| Akebia Therapeutics, Inc. | AKBA | $0.47 | -4.78% | 3,881 | 5,065 | $132 | $1.27 | -62.99% |
| Enliven Therapeutics, Inc. | ELVN | $48.80 | 1.01% | 973 | 1,306 | $3,591 | $14.90 | 227.52% |
| TG Therapeutics, Inc. | TGTX | $64.51 | -0.08% | 1,096 | 2,412 | $9,751 | $17.04 | 278.58% |
| Myriad Genetics, Inc. | MYGN | $5.66 | -0.35% | 1,045 | 1,619 | $543 | $19.00 | -70.21% |
| Ocular Therapeutix, Inc. | OCUL | $6.21 | -1.11% | 2,487 | 2,743 | $1,366 | $4.81 | 29.11% |
| Actuate Therapeutics Inc | ACTU | $0.29 | -3.61% | 174 | 251 | $7 | $8.61 | -96.63% |
| Shattuck Labs, Inc. | STTK | $4.65 | -3.33% | 776 | 1,238 | $474 | $7.56 | -38.49% |
| Abeona Therapeutics Inc. | ABEO | $2.42 | 5.68% | 3,174 | 1,237 | $138 | $5.61 | -56.86% |
| ProKidney Corp. | PROK | $1.05 | -9.13% | 1,292 | 1,125 | $351 | $1.73 | -39.31% |
| uniQure N.V. | QURE | $23.81 | -3.33% | 1,394 | 2,161 | $1,670 | $17.85 | 33.39% |
| Evommune, Inc. | EVMN | $7.63 | -4.86% | 723 | 782 | $315 | $17.32 | -55.95% |
| Ocugen, Inc. | OCGN | $0.83 | -5.24% | 16,649 | 7,595 | $281 | $1.36 | -38.97% |
| Prelude Therapeutics Incorporated | PRLD | $3.45 | -1.99% | 262 | 442 | $200 | $2.90 | 18.97% |
| Tango Therapeutics, Inc. | TNGX | $25.50 | 2.62% | 2,706 | 4,084 | $4,321 | $8.85 | 188.14% |
| Pyxis Oncology, Inc. | PYXS | $1.58 | 0.00% | 358 | 931 | $189 | $1.18 | 33.90% |
| Nuvation Bio Inc. | NUVB | $3.99 | -1.72% | 3,087 | 6,412 | $1,405 | $2.89 | 38.06% |
| Korro Bio, Inc. | KRRO | $13.61 | -4.89% | 79 | 192 | $196 | $42.84 | -68.23% |
| Talphera, Inc. | TLPH | $0.91 | -12.46% | 1,220 | 276 | $47 | $1.14 | -20.18% |
| BridgeBio Oncology Therapeutics Inc. | BBOT | $2.14 | -8.94% | 677 | 430 | $172 | $12.31 | -82.62% |
| Dyne Therapeutics, Inc. | DYN | $17.16 | 0.88% | 1,674 | 2,002 | $3,216 | $19.59 | -12.40% |
| CytomX Therapeutics, Inc. | CTMX | $2.04 | 0.00% | 2,725 | 4,255 | $445 | $1.13 | 80.53% |
| Serina Therapeutics, Inc. | SER | $1.39 | -1.42% | 11 | 90 | $21 | $2.15 | -35.35% |
| LENZ Therapeutics, Inc. | LENZ | $4.13 | 0.98% | 749 | 900 | $130 | $16.31 | -74.68% |
| Oncolytics Biotech Inc. | ONCY | $0.37 | -0.54% | 1,262 | 1,524 | $37 | $0.96 | -61.46% |
| BriaCell Therapeutics Corp. | BCTX | $3.39 | -3.42% | 25 | 203 | $30 | $7.23 | -53.11% |
| Protara Therapeutics, Inc. | TARA | $2.53 | 3.69% | 728 | 716 | $156 | $6.14 | -58.79% |
| Allogene Therapeutics, Inc. | ALLO | $0.84 | 1.41% | 11,544 | 8,034 | $291 | $2.24 | -62.50% |
| Pulse Biosciences, Inc. | PLSE | $50.44 | -3.46% | 591 | 352 | $3,710 | $19.63 | 156.95% |
| Sutro Biopharma, Inc. | STRO | $9.82 | 2.40% | 333 | 357 | $163 | $19.50 | -49.64% |
| ALX Oncology Holdings Inc. | ALXO | $1.04 | -3.70% | 673 | 1,306 | $144 | $1.13 | -7.96% |
| Erasca, Inc. | ERAS | $15.66 | -0.76% | 8,533 | 6,695 | $5,496 | $3.71 | 322.10% |
| Adlai Nortye Ltd. | ANL | $10.61 | 0.86% | 152 | 225 | $563 | $2.30 | 361.30% |
| Aquestive Therapeutics, Inc. | AQST | $3.91 | 9.52% | 3,962 | 0 | $491 | $3.58 | 9.22% |
| Arcturus Therapeutics Holdings Inc. | ARCT | $8.36 | -0.95% | 377 | 0 | $241 | $17.94 | -53.40% |
| Zura Bio Limited | ZURA | $1.24 | 0.00% | 4,239 | 0 | $119 | $2.58 | -51.94% |
| ArriVent BioPharma, Inc. | AVBP | $13.01 | -0.46% | 616 | 0 | $673 | $20.79 | -37.42% |
| Evaxion Biotech A/S | EVAX | $2.74 | -1.08% | 46 | 0 | $17 | $4.55 | -39.78% |
| Vir Biotechnology, Inc. | VIR | $9.96 | -17.82% | 16,659 | 0 | $1,706 | $14.03 | -29.01% |
